Alicia Lenzen

Assistant Professor, Pediatrics

Emailalicia.lenzen@northwestern.edu

48 Citations

If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Training Experience

2015	Internship, Advocate Christ Medical Center/Advocate Children's Hospital
2015	Residency, Advocate Children's Hospital, Oak Lawn
2018	Fellowship, Northwestern University, McGaw Medical Center (Lurie Children's Hospital)
2019	Fellowship, Northwestern University, McGaw Medical Center (Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois

Education/Academic qualification

MD, Brown University

… → 2011

Fingerprint Dive into the research topics where Alicia Lenzen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

10 Similar Profiles

Glioblastoma Medicine & Life Sciences

Indoleamine-Pyrrole 2,3,-Dioxygenase Medicine & Life Sciences

Vaccines Medicine & Life Sciences

Pediatrics Medicine & Life Sciences

Kynurenine Medicine & Life Sciences

Thrombasthenia Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Central Nervous System Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2015 2018

48 Citations
5 Article
2 Review article
1 Editorial

Clinical Trials 101 in Pediatric Oncology Patients

Lenzen, A. & Smiley, N. P., Jun 1 2018, In : Clinical Pediatric Emergency Medicine. 19, 2, p. 131-134 4 p.

Research output: Contribution to journal › Article

Clinical Trials

Pediatrics

Hospital Emergency Service

Therapeutics

Neoplasms

23 Citations (Scopus)

IDO1 in cancer: a Gemini of immune checkpoints

Zhai, L., Ladomersky, E., Lenzen, A., Nguyen, B., Patel, R., Lauing, K. L., Wu, M. & Wainwright, D. A., May 1 2018, In : Cellular and Molecular Immunology. 15, 5, p. 447-457 11 p.

Research output: Contribution to journal › Review article

Indoleamine-Pyrrole 2,3,-Dioxygenase

Neoplasms

Tryptophan

Kynurenine

Essential Amino Acids

16 Citations (Scopus)

IDO1 inhibition synergizes with radiation and PD-1 blockade to durably increase survival against advanced glioblastoma

Ladomersky, E., Zhai, L., Lenzen, A., Lauing, K. L., Qian, J., Scholtens, D. M., Gritsina, G., Sun, X., Liu, Y., Yu, F., Gong, W., Liu, Y., Jiang, B., Tang, T., Patel, R., Platanias, L. C., James, C. D., Stupp, R., Lukas, R. V., Binder, D. C. & 1 others, Wainwright, D. A., Jun 1 2018, In : Clinical Cancer Research. 24, 11, p. 2559-2573 15 p.

Research output: Contribution to journal › Article

Glioblastoma

Radiation

Survival

T-Lymphocytes

Therapeutics

Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma

Binder, D. C., Ladomersky, E., Lenzen, A., Zhai, L., Lauing, K. L., Otto-Meyer, S. D., Lukas, R. V. & Wainwright, D. A., Apr 1 2018, In : Translational Cancer Research. 7, p. S510-S513

Research output: Contribution to journal › Editorial

Glioblastoma

Therapeutics

epidermal growth factor receptor VIII

rindopepimut

Pediatric Central Nervous System Tumor Diagnosis, Complications, and Emergencies

Lenzen, A., Garcia-Sosa, R., Habiby, R. L., DiPatri, A. J. & Pillay Smiley, N., Jun 1 2018, In : Clinical Pediatric Emergency Medicine. 19, 2, p. 153-161 9 p.

Research output: Contribution to journal › Article

Central Nervous System Neoplasms

Emergencies

Pediatrics

Neurogenic Diabetes Insipidus

Neoplasms